Literature DB >> 22995747

Weight loss and vascular inflammatory markers in overweight women with and without polycystic ovary syndrome.

Lisa J Moran1, Manny Noakes, Gary A Wittert, Peter M Clifton, Robert J Norman.   

Abstract

Polycystic ovary syndrome (PCOS) is associated with increased cardiovascular disease risk. The effect of weight loss on the vascular inflammatory markers plasminogen activator inhibitor-1 (PAI-1), asymmetric dimethylarginine (ADMA), soluble vascular cell adhesion molecule-1 (sVCAM-1) and intracellular adhesion molecule-1 (sICAM-1) is unknown. Overweight women with (n=14) and without (n=13) PCOS of comparable age and body mass index undertook an 8-week weight-loss programme. Women with PCOS had elevated PAI-1, sVCAM-1 and sICAM-1 before and after weight loss compared with the controls. For all women, sVCAM-1 (P=0.026) and sICAM-1 (P=0.04) decreased with weight loss. Women with PCOS have elevated inflammatory markers, which are partially reduced by weight loss.
Copyright © 2012 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22995747     DOI: 10.1016/j.rbmo.2012.07.013

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  2 in total

1.  The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome.

Authors:  Zeeshan Javed; Maria Papageorgiou; Leigh A Madden; Alan S Rigby; Eric S Kilpatrick; Stephen L Atkin; Thozhukat Sathyapalan
Journal:  Endocr Connect       Date:  2020-06       Impact factor: 3.335

2.  Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development.

Authors:  Xiu-Xia Wang; Jing-Zan Wei; Jiao Jiao; Shu-Yi Jiang; Da-Hai Yu; Da Li
Journal:  Oncotarget       Date:  2014-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.